Erythroid differentiation intensifies RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
P. L. Moura, T. Mortera-Blanco, I. J. F. Hofman, G. Todisco, W. W. Kretzschmar, A.-C. Bjorklund, M. Creignou, M. Hagemann-Jensen, C. Ziegenhain, D. C. Granados, I. Barbosa, G. Walldin, M. Jansson, N. Ashley, A. J. Mead, V. Lundin, M. Dimitriou, T. Yoshizato, P. S. Woll, S. Ogawa, R. Sandberg, S. E. W. Jacobsen, E. Hellstrom-Lindberg
Abstract
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) commonly originate from mutations in the splicing factor SF3B1 (SF3B1mt). SF3B1mt cause RNA mis-splicing, mechanistically established as the major driver of RS development. However, little is known about RS fate and biology after their initial formation in the human bone marrow. We here achieve isolation of viable RS from patient samples, enabling the first complete investigation of SF3B1mt development from stem cell to RS. We show that RS skew MACS-isolated CD34+ data towards erythroid features not recapitulated in single-cell RNAseq. We demonstrate that RS divide, differentiate, enucleate and actively respond to mis-splicing/oxidative stress, decreasing wildtype stem cell fitness via GDF15 overproduction. We identify circulating RS as a uniform clinical feature associated with disease burden. Finally, we establish that SF3B1mt mis-splicing intensifies during erythroid differentiation and demonstrate through combined transcriptomics/proteomics an uncoupling of RNA/protein biology in RS encompassing severe and dysfunctional mis-splicing of proapoptotic genes. Statement of significanceWe here combine a novel method for RS isolation with state-of-the-art multiomics to perform the first complete investigation of SF3B1mt MDS-RS hematopoiesis from stem cell to RS. We identify the survival mechanisms underlying SF3B1mt erythropoiesis and establish an active role for erythroid differentiation and RS themselves in SF3B1mt MDS-RS pathogenesis.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes
J. L. Manley, Y. K. Lieu, … S. Mukherjee·bioRxiv·Jun 24, 2020
- CDK8 is a critical effector of cell fate dysregulation in SF3B1-mutant MDS
Elizabeth A. Bonner, Tun‐Yun Hsueh, … Stanley Chun-Wei Lee·bioRxiv·Aug 14, 2025
- SF3B1-mutant mis-splicing of UBA1 confers a targetable therapeutic vulnerability through UBA1 inhibition
Jonas Thier, Sophia Hofmann, … Vanessa Lundin·LeukemiaPeer-reviewed·Aug 26, 2025
- Single-cell multi-omics defines the cell-type specific impact of splicing aberrations in human hematopoietic clonal outgrowths
F. Gaiti, P. Chamely, … D. A. Landau·bioRxiv·Jun 8, 2022
- Only SF3B1 Mutation involving K700E (And Not Other Codons), Independently Predicts Overall Survival in Myelodysplastic Syndromes
R. Kanagal-Shamanna, G. Montalban-Bravo, … G. Garcia-Manero·bioRxiv·Sep 4, 2020
- Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS
He Tian Chen, Pratik Joshi, … Kristin J. Hope·BloodPeer-reviewed·Jun 20, 2026